IOVS Antimicrobial Agents and Chemotherapy
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2003;44:5075-5081.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.02-0457

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimitrov, P. N.
Right arrow Articles by Taylor, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimitrov, P. N.
Right arrow Articles by Taylor, H. R.

Five-Year Incidence of Bilateral Cause-Specific Visual Impairment in the Melbourne Visual Impairment Project

Peter N. Dimitrov,1 Bickol N. Mukesh,1,2 Catherine A. McCarty,1,3 and Hugh R. Taylor1

1From the Center for Eye Research Australia, University of Melbourne, Victoria, Australia; the 2Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia; and the 3Marshfield Medical Research Foundation, Marshfield Clinic, Marshfield, Wisconsin.

PURPOSE. To describe the age-, gender-, and cause-specific 5-year incidence of bilateral visual impairment in participants in the Melbourne Visual Impairment Project, Victoria, Australia.

METHODS. Participants aged 40 years and older were recruited from Melbourne, Victoria, Australia, by random cluster sampling. The mean age of the 3271 (83% of the eligible) participants was 59 ± 12 (SD) years. Of the participants, 54% were female. The initial baseline study (1992–1994) was followed by a 5-year incidence study (1997–1999). At both time points of the study, participants underwent a standardized testing procedure. Distance and near vision was tested using logarithm of the minimum angle of resolution (logMAR) charts, followed by refraction if needed. Visual fields were assessed by the 24-2 Humphrey field test (FastPac, Humphrey Field Analyzer; Carl Zeiss Meditec, Dublin, CA). Also, intraocular pressure, ocular motility, dilated ophthalmoscopy, and photography of the lens and the fundus were conducted. Furthermore, an interview included demographic characteristics, history of eye disease, medical history, and medication use. For classification of visual impairment, both visual acuity (VA) and visual fields (VF) examination results were used. Four levels of bilateral presenting visual impairment were defined: mild (VA, <20/40–20/60, and/or VF, homonymous hemianopia), moderate (VA, <20/60–20/200, and/or VF, constriction <20° to 10° from fixation), severe (VA, <20/200–10/200, and/or VF, constriction <10° to 5° from fixation), and profound (VA, <10/200, and/or VF, constriction <5° from fixation). For all participants found to be visually impaired, the major cause was identified.

RESULTS. Of the 3040 people eligible to attend follow-up 2594 (85%) participated. Data were available for 2530 (98%) participants. In 105 participants (4.22%; 95% confidence limit 2.58–5.85) some degree of visual impairment developed. The main causes were undercorrected refractive error (59%), age-related macular degeneration, cataract and neuro-ophthalmic disorders (7% each), glaucoma (3%), and diabetic retinopathy (1%). The main cause of severe and profound visual impairment was age-related macular degeneration (37%).

CONCLUSIONS. Undercorrected refractive error was the primary cause of new cases of visual impairment in this population. Further research is needed to understand the origin of this and to develop appropriate prevention measures. Age-related macular degeneration is the primary cause of severe or profound vision loss in Australia. This disease requires further investigation for effective cure and preventive strategies.





This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
M Rosman, T Y Wong, W Wong, M L Wong, and S-M Saw
Knowledge and beliefs associated with refractive errors and undercorrection: the Singapore Malay Eye Study
Br. J. Ophthalmol., January 1, 2009; 93(1): 4 - 10.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. Vitale, M. F. Cotch, and R. D. Sperduto
Prevalence of visual impairment in the United States.
JAMA, May 10, 2006; 295(18): 2158 - 2163.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. Robman, O. Mahdi, C. McCarty, P. Dimitrov, G. Tikellis, J. McNeil, G. Byrne, H. Taylor, and R. Guymer
Exposure to Chlamydia pneumoniae Infection and Progression of Age-related Macular Degeneration
Am. J. Epidemiol., June 1, 2005; 161(11): 1013 - 1019.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology